Vital signs continuously monitored by two wearable devices in pediatric oncology patients, NCT04914702

Area of Science:

• Oncology
• Biomedical Engineering
• Pediatrics

Background:

• Fever in neutropenia is a serious complication in pediatric cancer patients undergoing chemotherapy.
• Early detection of fever is crucial for timely intervention and improved patient outcomes.
• Continuous monitoring offers a potential advancement over intermittent temperature measurements.

Purpose of the Study:

• To evaluate the feasibility of continuous temperature monitoring using wearable devices in pediatric cancer patients.
• To assess the data quality and usability of two specific wearable devices (CORE® and Everion®).
• To explore the potential of wearable devices for early fever detection in this vulnerable population.

Main Methods:

• Prospective, two-center, observational, proof-of-concept study.
• Recruitment of pediatric patients undergoing chemotherapy for cancer.
• 14-day continuous monitoring with CORE® and Everion® wearable devices, recording core temperature and other vital signs.
• Collection of non-wearable data including acceptability, side effects, and intermittent ear temperature measurements.

Main Results:

• Extensive data collected: 4945 hours (CORE®) and 5360 hours (Everion®).
• Over 6 million vital sign and health score measurements recorded across both devices.
• Data generated for evaluating device acceptability, usability, compliance, and data quality.

Conclusions:

• Continuous temperature monitoring with wearable devices is feasible in pediatric cancer patients undergoing chemotherapy.
• The collected data supports further research into the utility of CORE® and Everion® for fever detection and vital sign monitoring.
• Wearable technology holds potential for improving the management of fever in neutropenia episodes in pediatric oncology.